EP1328151A4 - Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer - Google Patents
Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancerInfo
- Publication number
- EP1328151A4 EP1328151A4 EP00953630A EP00953630A EP1328151A4 EP 1328151 A4 EP1328151 A4 EP 1328151A4 EP 00953630 A EP00953630 A EP 00953630A EP 00953630 A EP00953630 A EP 00953630A EP 1328151 A4 EP1328151 A4 EP 1328151A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- hyde
- cancer
- proteins
- induction
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30245799A | 1999-04-29 | 1999-04-29 | |
US13160799P | 1999-04-29 | 1999-04-29 | |
US302457 | 1999-04-29 | ||
US131607P | 1999-04-29 | ||
US499817 | 2000-02-08 | ||
US09/499,817 US7043009B1 (en) | 2000-02-08 | 2000-02-08 | Providing customer data to an automatic call distribution system agent |
PCT/US2000/011456 WO2000071564A2 (en) | 1999-04-29 | 2000-05-01 | Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1328151A2 EP1328151A2 (en) | 2003-07-23 |
EP1328151A4 true EP1328151A4 (en) | 2004-06-16 |
Family
ID=27384176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00953630A Withdrawn EP1328151A4 (en) | 1999-04-29 | 2000-05-01 | Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1328151A4 (en) |
JP (1) | JP2003529321A (en) |
AU (1) | AU769889B2 (en) |
CA (1) | CA2371828A1 (en) |
WO (1) | WO2000071564A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6835812B1 (en) | 1999-04-29 | 2004-12-28 | University Of Tennessee Research Corporation | Human p-Hyde proteins |
CN113507933B (en) * | 2019-03-05 | 2024-05-10 | 陶氏环球技术有限责任公司 | Induction of caspase Activity |
CN113106082B (en) * | 2021-05-27 | 2022-11-04 | 云南师范大学 | Animal waste metagenome-derived alanine racemase and preparation and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1074617A2 (en) * | 1999-07-29 | 2001-02-07 | Helix Research Institute | Primers for synthesising full-length cDNA and their use |
WO2001059127A2 (en) * | 2000-02-11 | 2001-08-16 | Incyte Genomics, Inc. | Drug metabolizing enzymes |
WO2001072962A2 (en) * | 2000-03-24 | 2001-10-04 | Fahri Saatcioglu | Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE307886T1 (en) * | 1995-12-20 | 2005-11-15 | Cerenis | NUCLEOTIDE SEQUENCES, PROTEINS, MEDICATIONS AND DIAGNOSTIC AGENTS FOR USE IN CANCER TREATMENT |
-
2000
- 2000-05-01 EP EP00953630A patent/EP1328151A4/en not_active Withdrawn
- 2000-05-01 WO PCT/US2000/011456 patent/WO2000071564A2/en active IP Right Grant
- 2000-05-01 AU AU66046/00A patent/AU769889B2/en not_active Ceased
- 2000-05-01 JP JP2000619819A patent/JP2003529321A/en active Pending
- 2000-05-01 CA CA002371828A patent/CA2371828A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1074617A2 (en) * | 1999-07-29 | 2001-02-07 | Helix Research Institute | Primers for synthesising full-length cDNA and their use |
WO2001059127A2 (en) * | 2000-02-11 | 2001-08-16 | Incyte Genomics, Inc. | Drug metabolizing enzymes |
WO2001072962A2 (en) * | 2000-03-24 | 2001-10-04 | Fahri Saatcioglu | Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
Non-Patent Citations (6)
Title |
---|
AMSON R B ET AL: "ISOLATION OF 10 DIFFERENTIALLY EXPRESSED CNDAS IN P53-INDUCED APOPTOSIS: ACTIVATION OF THE VERTEBRATE HOMOLOGUE OF THE DROSOPHILA SEVEN IN ABSENTIA GENE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 9, 30 April 1996 (1996-04-30), pages 3953 - 3957, XP002032914, ISSN: 0027-8424 * |
DATABASE EMBL [online] EBI; 22 February 2000 (2000-02-22), "Homo sapiens cDNA FLJ10829 fis, clone NT2RP4001138", XP002276044, retrieved from EMBL Database accession no. AK001691 * |
JOHNSON M.I.; HAMDY F.C.: "Apoptosis regulating genes in prostate cancer (Review)", ONCOLOGY REPORTS, vol. 5, no. 3, May 1998 (1998-05-01), pages 553 - 557, XP009028911 * |
RINALDY A R ET AL: "Role of pHyde novel gene product as an intrinsic factor for apoptotic pathway in prostate cancer.", GAN TO KAGAKU RYOHO. CANCER & CHEMOTHERAPY. JAPAN MAY 2000, vol. 27 Suppl 2, May 2000 (2000-05-01), pages 215 - 222, XP009028708, ISSN: 0385-0684 * |
STEINER M S ET AL: "GROWTH INHIBITION OF PROSTATE CANCER BY AN ADENOVIRUS EXPRESSING A NOVEL TUMOR SUPPRESSOR GENE, PHYDE", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 60, no. 16, 15 August 2000 (2000-08-15), pages 4419 - 4425, XP001076638, ISSN: 0008-5472 * |
ZHANG X ET AL: "APOPTOSIS INDUCTION IN PROSTATE CANCER CELLS BY A NOVEL GENE PRODUCT, PHYDE, INVOLVES CASPASE-3", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 20, no. 42, 20 September 2001 (2001-09-20), pages 5982 - 5990, XP008003138, ISSN: 0950-9232 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000071564A8 (en) | 2001-10-04 |
WO2000071564A2 (en) | 2000-11-30 |
AU6604600A (en) | 2000-12-12 |
WO2000071564A3 (en) | 2003-05-01 |
EP1328151A2 (en) | 2003-07-23 |
CA2371828A1 (en) | 2000-11-30 |
AU769889B2 (en) | 2004-02-05 |
JP2003529321A (en) | 2003-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0200773A3 (en) | Methods of inducing cacer cell death and tumor regression | |
EP1244465A4 (en) | Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions | |
SI1576132T1 (en) | Nucleic acids entitled 273p4b7 and their use in detection of cancer | |
GB9917307D0 (en) | Improvements in and relating to analysis of DNA | |
HK1152714A1 (en) | Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer steap-1 | |
EP1537140A4 (en) | Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer | |
AU3997300A (en) | Gene sequence variations with utility in determining the treatment of disease | |
EP0927270A4 (en) | Lyophilization of cultured human cells to preserve rna and dna | |
AU1186202A (en) | Methods of inducing cancer cell death and tumor regression | |
EP1622571A4 (en) | Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer | |
EP1590437A4 (en) | Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer | |
EP1372719A4 (en) | Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer | |
EP1186615A4 (en) | Novel protein and dna thereof | |
EP1328151A4 (en) | Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer | |
AU2001285018A1 (en) | Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer | |
EP1409710A4 (en) | Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer | |
AU2003268355A8 (en) | Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells | |
MXPA01010890A (en) | Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer. | |
IL155951A0 (en) | Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
HUP0303890A3 (en) | Expression amalysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
AU1576501A (en) | Methods to enhance and confine gene expression in cancer therapy | |
IL156973A0 (en) | Mammalian tumor susceptibility gene products and their uses | |
IL147071A0 (en) | Nucleic and proteinic acids corresponding to human gene abc1 | |
AU2001286541A1 (en) | Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer | |
HUP0303899A3 (en) | Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011112 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 12N 15/861 B Ipc: 7A 61K 31/7052 B Ipc: 7C 12Q 1/70 B Ipc: 7G 01N 33/574 B Ipc: 7C 07K 16/30 B Ipc: 7C 12N 15/12 B Ipc: 7C 07K 14/47 B Ipc: 7A 01K 67/027 B Ipc: 7C 12P 21/00 B Ipc: 7A 61P 35/00 B Ipc: 7C 07K 19/00 B Ipc: 7C 07K 16/00 B Ipc: 7A 61K 48/00 B Ipc: 7C 07H 21/00 B Ipc: 7C 12N 15/62 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040504 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080411 |